A detailed history of Adar1 Capital Management, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 120,663 shares of FGEN stock, worth $69,984. This represents 0.01% of its overall portfolio holdings.

Number of Shares
120,663
Holding current value
$69,984
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.33 - $1.26 $39,818 - $152,035
120,663 New
120,663 $48.2 Million
Q1 2024

May 15, 2024

BUY
$0.73 - $2.73 $15,585 - $58,285
21,350 New
21,350 $50.2 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $54.4M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.